Immunogenicity of subcutaneous TNF inhibitors and its clinical significance in real-life setting in patients with spondyloarthritis
J. Hiltunen, P. Parmanne, T. Sokka, T. Lamberg, P. Isomäki, O. Kaipiainen-Seppänen, R. Peltomaa, T. Uutela, L. Pirilä, K. Taimen, M. J. Kauppi, T. Yli-Kerttula, R. Tuompo, H. Relas, S. Kortelainen, K. Paalanen, J. Asikainen, P. Ekman, A. Santisteban, K. L. VidqvistK. Tadesse, M. Romu, J. Borodina, P. Elfving, H. Valleala, M. Leirisalo-Repo, V. Rantalaiho, H. Kautiainen, T. S. Jokiranta, K. K. Eklund, for the FinADASpA Study Group
Research output: Contribution to journal › Article › Scientific › peer-review
3Citations
(Scopus)
33Downloads
(Pure)
Fingerprint
Dive into the research topics of 'Immunogenicity of subcutaneous TNF inhibitors and its clinical significance in real-life setting in patients with spondyloarthritis'. Together they form a unique fingerprint.